Cargando…

Polymer micelle formulation for the proteasome inhibitor drug carfilzomib: Anticancer efficacy and pharmacokinetic studies in mice

Carfilzomib (CFZ) is a peptide epoxyketone proteasome inhibitor approved for the treatment of multiple myeloma (MM). Despite the remarkable efficacy of CFZ against MM, the clinical trials in patients with solid cancers yielded rather disappointing results with minimal clinical benefits. Rapid degrad...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Ji Eun, Chun, Se-Eun, Reichel, Derek, Min, Jee Sun, Lee, Su-Chan, Han, Songhee, Ryoo, Gongmi, Oh, Yunseok, Park, Shin-Hyung, Ryu, Heon-Min, Kim, Kyung Bo, Lee, Ho-Young, Bae, Soo Kyung, Bae, Younsoo, Lee, Wooin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342227/ https://www.ncbi.nlm.nih.gov/pubmed/28273121 http://dx.doi.org/10.1371/journal.pone.0173247

Ejemplares similares

H727 cells are inherently resistant to the proteasome inhibitor carfilzomib, yet require proteasome activity for cell survival and growth
por: Lee, Min Jae, et al.
Publicado: (2019)

Nanoparticulate formulations of mithramycin analogs for enhanced cytotoxicity
por: Scott, Daniel, et al.
Publicado: (2011)

Dual Functioned Pegylated Phospholipid Micelles Containing Cationic Antimicrobial Decapeptide for Treating Sepsis
por: Lee, Wonhwa, et al.
Publicado: (2017)

Investigating the Vascular Toxicity Outcomes of the Irreversible Proteasome Inhibitor Carfilzomib
por: Efentakis, Panagiotis, et al.
Publicado: (2020)

Dual-responsive Gemini Micelles for Efficient Delivery of Anticancer Therapeutics
por: Choi, Young In, et al.
Publicado: (2019)

Ubiquitin–proteasome system (UPS) as a target for anticancer treatment
por: Park, Jinyoung, et al.
Publicado: (2020)

Deubiquitination Reactions on the Proteasome for Proteasome Versatility
por: Shin, Ji Yeong, et al.
Publicado: (2020)

Insulin-Degrading Enzyme Is a Non Proteasomal Target of Carfilzomib and Affects the 20S Proteasome Inhibition by the Drug
por: Tundo, Grazia Raffaella, et al.
Publicado: (2022)

Non-convulsive seizure related to Cremophor EL™-free, polymeric micelle formulation of paclitaxel: a case report
por: Shin, Yoon Sun, et al.
Publicado: (2018)

Enhanced anticancer activity and intracellular uptake of paclitaxel-containing solid lipid nanoparticles in multidrug-resistant breast cancer cells
por: Xu, Wenting, et al.
Publicado: (2018)

An Open-Label, Randomized, Parallel, Phase III Trial Evaluating the Efficacy and Safety of Polymeric Micelle-Formulated Paclitaxel Compared to Conventional Cremophor EL-Based Paclitaxel for Recurrent or Metastatic HER2-Negative Breast Cancer
por: Park, In Hae, et al.
Publicado: (2017)

Spasmogenic Effects of the Proteasome Inhibitor Carfilzomib on Coronary Resistance, Vascular Tone and Reactivity
por: Chen-Scarabelli, Carol, et al.
Publicado: (2017)

Carfilzomib: A Promising Proteasome Inhibitor for the Treatment of Relapsed and Refractory Multiple Myeloma
por: Jayaweera, Shansa Pranami E., et al.
Publicado: (2021)

Development and Evaluation of a Water Soluble Fluorometholone Eye Drop Formulation Employing Polymeric Micelle
por: Noh, Gyubin, et al.
Publicado: (2018)

Combination treatment with doxorubicin and gamitrinib synergistically augments anticancer activity through enhanced activation of Bim
por: Park, Hye-Kyung, et al.
Publicado: (2014)

Caspase-4 disaggregates lipopolysaccharide micelles via LPS-CARD interaction
por: An, Jinsu, et al.
Publicado: (2019)

Nelfinavir augments proteasome inhibition by bortezomib in myeloma cells and overcomes bortezomib and carfilzomib resistance
por: Kraus, M, et al.
Publicado: (2013)

Second-generation proteasome inhibitor carfilzomib sensitizes neuroblastoma cells to doxorubicin-induced apoptosis
por: Guan, Shan, et al.
Publicado: (2016)

Clinical activity of carfilzomib correlates with inhibition of multiple proteasome subunits: application of a novel pharmacodynamic assay
por: Lee, Susan J., et al.
Publicado: (2016)

Ethacrynic Acid: A Promising Candidate for Drug Repurposing as an Anticancer Agent
por: Yu, Lu, et al.
Publicado: (2023)

Preclinical evaluation of injectable sirolimus formulated with polymeric nanoparticle for cancer therapy
por: Woo, Ha Na, et al.
Publicado: (2012)

Incorporating hematopoietic stem-cell transplantation after second-line carfilzomib-lenalidomide-dexamethasone (KRd)
por: Byun, Ja Min, et al.
Publicado: (2020)

PSMB9 Codon 60 Polymorphisms Have No Impact on the Activity of the Immunoproteasome Catalytic Subunit B1i Expressed in Multiple Types of Solid Cancer
por: Park, Ji Eun, et al.
Publicado: (2013)

Polymeric micelles loaded with carfilzomib increase tolerability in a humanized bone marrow-like scaffold mouse model
por: Varela-Moreira, Aida, et al.
Publicado: (2020)

In Vitro Inhibition of Human UDP-Glucuronosyl-Transferase (UGT) Isoforms by Astaxanthin, β-Cryptoxanthin, Canthaxanthin, Lutein, and Zeaxanthin: Prediction of in Vivo Dietary Supplement-Drug Interactions
por: Zheng, Yu Fen, et al.
Publicado: (2016)

The novel proteasome inhibitor carfilzomib activates and enhances extrinsic apoptosis involving stabilization of death receptor 5
por: Han, Bo, et al.
Publicado: (2015)

Second-generation proteasome inhibitor carfilzomib enhances doxorubicin-induced cytotoxicity and apoptosis in breast cancer cells
por: Shi, Yonghua, et al.
Publicado: (2016)

Proteasome Inhibition by Carfilzomib Induced Apotosis and Autophagy in a T-cell Acute Lymphoblastic Leukemia Cell Line
por: Hosseini, Maryam Sadat, et al.
Publicado: (2019)

Targeted Protein Degradation: Principles and Applications of the Proteasome
por: Kim, Yosup, et al.
Publicado: (2023)

Neoadjuvant chemoradiation alters biomarkers of anticancer immunotherapy responses in locally advanced rectal cancer
por: Seo, Incheol, et al.
Publicado: (2021)

Identification of a Clinical Cutoff Value for Multiplex KRAS(G12/G13) Mutation Detection in Colorectal Adenocarcinoma Patients Using Digital Droplet PCR, and Comparison with Sanger Sequencing and PNA Clamping Assay
por: Lee, Kyung Ha, et al.
Publicado: (2020)

Colorectal cancer lung metastasis treatment with polymer–drug nanoparticles
por: Rychahou, Piotr, et al.
Publicado: (2018)

Anesthetic experience in a child with femoral hypoplasia-unusual facies syndrome
por: Kang, Mae Hwa, et al.
Publicado: (2013)

Dendritic Cell-Targeted pH-Responsive Extracellular Vesicles for Anticancer Vaccination
por: Lee, Hyuk, et al.
Publicado: (2019)

NQO1 inhibits proteasome-mediated degradation of HIF-1α
por: Oh, Eun-Taex, et al.
Publicado: (2016)

Evaluation of the Physicochemical Properties, Pharmacokinetics, and In Vitro Anticancer Effects of Docetaxel and Osthol Encapsulated in Methoxy Poly(ethylene glycol)-b-Poly(caprolactone) Polymeric Micelles
por: Jo, Min Jeong, et al.
Publicado: (2020)

Smart Polymeric Micelles for Anticancer Hydrophobic Drugs
por: Guzmán Rodríguez, Andy, et al.
Publicado: (2022)

Tailored CVD graphene coating as a transparent and flexible gas barrier
por: Seo, Tae Hoon, et al.
Publicado: (2016)

Concept and application of circulating proteasomes
por: Choi, Won Hoon, et al.
Publicado: (2021)

Chromosome-level genome assembly of the Asian aspen Populus davidiana Dode
por: Bae, Eun-Kyung, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_81u6d59f6mfbrmtf79rs861ctl